Header Logo

James N George

TitleProf,George L Cross Rsrch
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentBiostatistics & Epidemiology
AddressCOHB 358
801 NE 13th St
Oklahoma City OK 73104
Phone405/271-4222
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R13HL084862     (GEORGE, JAMES N)Aug 23, 2006 - Jul 31, 2007
    NIH
    2006 Clinical Research Training Institute
    Role: Principal Investigator
    R13HL082191     (GEORGE, JAMES N)Aug 19, 2005 - Jul 31, 2006
    NIH
    Clinical Research Training Institute
    Role: Principal Investigator
    U01HL072283     (GEORGE, JAMES N)Sep 30, 2002 - Aug 31, 2014
    NIH
    Oklahoma-UT Southwestern Hemostasis Consortium
    Role: Principal Investigator
    R01HL019996     (GEORGE, JAMES N)Dec 1, 1976 - Jun 30, 1986
    NIH
    THE ROLE OF MEMBRANE PROTEINS IN PLATELET FUNCTION
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Shi H, Gao L, Kirby N, Shao B, Shan X, Kudo M, Silasi R, McDaniel MJ, Zhou M, McGee S, Jing W, Lupu F, Cleuren A, George JN, Xia L. Clearance of VWF by hepatic macrophages is critical for the protective effect of ADAMTS13 in sickle cell anemia mice. Blood. 2023 Dec 24. PMID: 38142410.
      Citations:    Fields:    
    2. Nusrat S, Davis H, MacDougall K, George JN, Nakamura R, Borogovac A. Thrombotic Microangiopathy After Hematopoietic Stem Cell and Solid Organ Transplantation: A Review for Intensive Care Physicians. J Intensive Care Med. 2023 Nov 21; 8850666231200193. PMID: 37990516.
      Citations:    Fields:    
    3. Nusrat S, Beg K, Khan O, Sinha A, George J. Hereditary Thrombotic Thrombocytopenic Purpura. Genes (Basel). 2023 10 18; 14(10). PMID: 37895305; PMCID: PMC10606562.
      Citations:    Fields:    Translation:Humans
    4. Khan S, George JN, Nusrat S. Drug-induced thrombotic microangiopathy and thrombotic thrombocytopenic purpura: A systematic review, 2018-2023. Am J Hematol. 2023 Sep 27. PMID: 37753669.
      Citations: 1     Fields:    Translation:Humans
    5. Barton JC, Anderson C, Miranda FZ, Kelley R, Kremer Hovinga JA, Terrell D, Vesely SK, George JN, Muia J. Cattle-FRETS71, a novel fluorogenic substrate with broad applicability for characterizing ADAMTS13 properties and function. J Thromb Haemost. 2023 Aug 25. PMID: 37633642.
      Citations:    Fields:    Translation:HumansAnimalsCells
    6. George JN. Hereditary thrombotic thrombocytopenic purpura: The risk for death at birth. Res Pract Thromb Haemost. 2022 Nov; 6(8):e12840. PMID: 36397935; PMCID: PMC9663672.
      Citations: 1     
    7. Wills-Sanin B, George JN, Boiocchi L, Soff GA, Mones JV. Occult recurrent breast cancer masquerading as thrombotic thrombocytopenic purpura. Am J Hematol. 2023 May; 98(5):830-832. PMID: 36222494.
      Citations: 1     Fields:    Translation:Humans
    8. Tarasco E, von Krogh AS, Hrdlickova R, Braschler TR, Iwaniec T, Kn?bl PN, Hamada E, Pikovsky O, Farese S, Gutwein O, Kessler P, Schultz NH, von Auer C, Windyga J, Friedman K, Hrachovinova I, George JN, Matsumoto M, Schneppenheim R, L?mmle B, Kremer Hovinga JA. Hereditary thrombotic thrombocytopenic purpura and COVID-19: Impacts of vaccination and infection in this rare disease. Res Pract Thromb Haemost. 2022 Oct; 6(7):e12814. PMID: 36284639; PMCID: PMC9585384.
      Citations:    
    9. Borogovac A, Tarasco E, Kremer Hovinga JA, Friedman KD, Asch AS, Vesely SK, Prodan CI, Terrell DR, George JN. Prevalence of neuropsychiatric symptoms and stroke in patients with hereditary thrombotic thrombocytopenic purpura. Blood. 2022 08 18; 140(7):785-789. PMID: 35584244.
      Citations: 3     Fields:    Translation:Humans
    10. Shi H, Shao B, Gao L, Venkatesan T, McDaniel JM, Zhou M, McGee S, Yu P, Ahamed J, Journeycake J, George JN, Xia L. Endothelial VWF is critical for the pathogenesis of vaso-occlusive episode in a mouse model of sickle cell disease. Proc Natl Acad Sci U S A. 2022 08 23; 119(34):e2207592119. PMID: 35969769; PMCID: PMC9407592.
      Citations: 6     Fields:    Translation:AnimalsCells
    11. George JN. Thrombotic Thrombocytopenic Purpura: From 1972 to 2022 and Beyond. Semin Thromb Hemost. 2022 Jul 06. PMID: 35793688.
      Citations:    Fields:    Translation:Humans
    12. Shao B, Nusrat S, George JN, Xia L. Aspirin prophylaxis for hereditary and acquired thrombotic thrombocytopenic purpura? Am J Hematol. 2022 08; 97(8):E304-E306. PMID: 35593427.
      Citations: 1     Fields:    Translation:Humans
    13. George JN. Thrombotic thrombocytopenic purpura: Crossing to safety. Transfusion. 2022 06; 62(6):1166-1170. PMID: 35680719.
      Citations:    Fields:    Translation:Humans
    14. Shao B, Hoover C, Shi H, Kondo Y, Lee RH, Chen J, Shan X, Song J, McDaniel JM, Zhou M, McGee S, Vanhoorelbeke K, Bergmeier W, López JA, George JN, Xia L. Deletion of platelet CLEC-2 decreases GPIba-mediated integrin aIIbß3 activation and decreases thrombosis in TTP. Blood. 2022 04 21; 139(16):2523-2533. PMID: 35157766.
      Citations: 9     Fields:    Translation:HumansCells
    15. Nusrat S, Borogovac A, George JN, Curtis BR, Reese JA. Drug (vaccine)-induced thrombocytopenia 2021: Diversity of pathogenesis and clinical features. Am J Hematol. 2022 04; 97(4):E162-E165. PMID: 35092624.
      Citations:    Fields:    Translation:Humans
    16. Borogovac A, Reese JA, Gupta S, George JN. Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura. Blood Adv. 2022 02 08; 6(3):750-759. PMID: 34807988.
      Citations: 9     Fields:    Translation:Humans
    17. Perez Botero J, Reese JA, George JN, McIntosh JJ. Severe thrombocytopenia and microangiopathic hemolytic anemia in pregnancy: A guide for the consulting hematologist. Am J Hematol. 2021 12 01; 96(12):1655-1665. PMID: 34424560.
      Citations: 7     Fields:    Translation:Humans
    18. Bolton-Maggs PHB, George JN. Immune Thrombocytopenia Treatment. N Engl J Med. 2021 09 02; 385(10):948-950. PMID: 34469652.
      Citations: 5     Fields:    Translation:Humans
    19. Tarasco E, Bütikofer L, Friedman KD, George JN, Hrachovinova I, Knöbl PN, Matsumoto M, von Krogh AS, Aebi-Huber I, Cermakova Z, Górska-Kosicka M, Jalowiec KA, Largiadèr CR, Prohászka Z, Sinkovits G, Windyga J, Lämmle B, Kremer Hovinga JA. Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura. Blood. 2021 06 24; 137(25):3563-3575. PMID: 33649760.
      Citations: 13     Fields:    Translation:Humans
    20. Cuker A, Cataland SR, Coppo P, de la Rubia J, Friedman KD, George JN, Knoebl PN, Kremer Hovinga JA, Lämmle B, Matsumoto M, Pavenski K, Peyvandi F, Sakai K, Sarode R, Thomas MR, Tomiyama Y, Veyradier A, Westwood JP, Scully M. Redefining outcomes in immune TTP: an international working group consensus report. Blood. 2021 04 08; 137(14):1855-1861. PMID: 33529333.
      Citations: 51     Fields:    Translation:Humans
    21. Siddiqui A, Journeycake JM, Borogovac A, George JN. Recognizing and managing hereditary and acquired thrombotic thrombocytopenic purpura in infants and children. Pediatr Blood Cancer. 2021 05; 68(5):e28949. PMID: 33660913.
      Citations: 7     Fields:    Translation:Humans
    22. George JN. TTP: the evolution of clinical practice. Blood. 2021 02 11; 137(6):719-720. PMID: 33570615.
      Citations: 6     Fields:    Translation:Humans
    23. Kasht R, Borogovac A, George JN. Frequency and severity of pregnancy complications in women with hereditary thrombotic thrombocytopenic purpura. Am J Hematol. 2020 11; 95(11):E316-E318. PMID: 32808675.
      Citations: 4     Fields:    Translation:Humans
    24. Avery EJ, Kenney SP, Byers BD, McIntosh JJ, Hoover C, Jiang Y, Xia L, Yu Z, George JN. Thrombotic thrombocytopenic purpura masquerading as preclampsia with severe features at 13?weeks' gestation. Am J Hematol. 2020 Jun 29. PMID: 32602158.
      Citations: 3     Fields:    
    25. Borogovac A, Tarasco E, Hovinga JAK, George JN. Hypertension in patients with hereditary thrombotic thrombocytopenic purpura. EJHaem. 2020 Jul; 1(1):342-343. PMID: 35847717.
      Citations: 1     
    26. Kremer Hovinga JA, George JN. Hereditary Thrombotic Thrombocytopenic Purpura. Reply. N Engl J Med. 2020 01 23; 382(4):394-395. PMID: 31971693.
      Citations:    Fields:    Translation:Humans
    27. Sukumar S, George JN, Cataland SR. Shared decision making, thrombotic thrombocytopenic purpura, and caplacizumab. Am J Hematol. 2020 04; 95(4):E76-E77. PMID: 31894592.
      Citations: 9     Fields:    Translation:Humans
    28. Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF, Kühne T, Kuter DJ, Lim W, McCrae KR, Pruitt B, Shimanek H, Vesely SK. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019 12 10; 3(23):3829-3866. PMID: 31794604.
      Citations: 299     Fields:    Translation:Humans
    29. Borogovac A, George JN. Stroke and myocardial infarction in hereditary thrombotic thrombocytopenic purpura: similarities to sickle cell anemia. Blood Adv. 2019 12 10; 3(23):3973-3976. PMID: 31805189.
      Citations: 7     Fields:    Translation:Humans
    30. Cuker A, George JN. Treatment of Immune Thrombocytopenia in Adults: Version 2019. Mayo Clin Proc. 2019 11; 94(11):2161-2163. PMID: 31685145.
      Citations:    Fields:    Translation:Humans
    31. Kremer Hovinga JA, George JN. Hereditary Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2019 10 24; 381(17):1653-1662. PMID: 31644845.
      Citations: 37     Fields:    Translation:Humans
    32. Saliba CK, George JN. Preventable deaths during initial episodes of acquired Thrombotic Thrombocytopenic Purpura: Past and future. Am J Hematol. 2019 09; 94(9):E242-E244. PMID: 31222788.
      Citations:    Fields:    Translation:Humans
    33. Prodan CI, Vijayvargiya P, Feisal JK, Khawandanah MO, Jiang Y, George JN. Embolic stroke of undetermined source in a young woman. Am J Hematol. 2019 09; 94(9):1044-1048. PMID: 31197838.
      Citations: 4     Fields:    Translation:Humans
    34. Chander DP, Loch MM, Cataland SR, George JN. Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2019 07 04; 381(1):92-94. PMID: 31269374.
      Citations: 23     Fields:    Translation:Humans
    35. George JN. Congenital TTP: toward a turning point. Blood. 2019 04 11; 133(15):1615-1617. PMID: 30975641.
      Citations: 1     Fields:    Translation:Humans
    36. Hassan A, Iqbal M, George JN. Additional autoimmune disorders in patients with acquired autoimmune thrombotic thrombocytopenic purpura. Am J Hematol. 2019 06; 94(6):E172-E174. PMID: 30895642.
      Citations: 8     Fields:    Translation:Humans
    37. van Dorland HA, Taleghani MM, Sakai K, Friedman KD, George JN, Hrachovinova I, Knöbl PN, von Krogh AS, Schneppenheim R, Aebi-Huber I, Bütikofer L, Largiadèr CR, Cermakova Z, Kokame K, Miyata T, Yagi H, Terrell DR, Vesely SK, Matsumoto M, Lämmle B, Fujimura Y, Kremer Hovinga JA. The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017. Haematologica. 2019 10; 104(10):2107-2115. PMID: 30792199.
      Citations: 52     Fields:    Translation:HumansCTClinical Trials
    38. Mitta A, Curtis BR, Reese JA, George JN. Drug-induced thrombocytopenia: 2019 Update of clinical and laboratory data. Am J Hematol. 2019 03; 94(3):E76-E78. PMID: 30549322.
      Citations: 15     Fields:    Translation:HumansCells
    39. Saleem R, Rogers ZR, Neunert C, George JN. Maintenance rituximab for relapsing thrombotic thrombocytopenic purpura: a case report. Transfusion. 2019 03; 59(3):921-926. PMID: 30548440.
      Citations: 2     Fields:    Translation:Humans
    40. George JN. TTP: long-term outcomes following recovery. Hematology Am Soc Hematol Educ Program. 2018 11 30; 2018(1):548-552. PMID: 30504356.
      Citations: 19     Fields:    Translation:Humans
    41. Coppo P, Cuker A, George JN. Thrombotic thrombocytopenic purpura: Toward targeted therapy and precision medicine. Res Pract Thromb Haemost. 2019 Jan; 3(1):26-37. PMID: 30656273.
      Citations: 27     
    42. Reese JA, Peck JD, Yu Z, Scordino TA, Deschamps DR, McIntosh JJ, Terrell DR, Vesely SK, George JN. Platelet sequestration and consumption in the placental intervillous space contribute to lower platelet counts during pregnancy. Am J Hematol. 2019 01; 94(1):E8-E11. PMID: 30328633.
      Citations: 7     Fields:    Translation:Humans
    43. George JN, McIntosh JJ, Reese JA. Platelet Counts during Pregnancy. N Engl J Med. 2018 10 18; 379(16):1581-1582. PMID: 30332565.
      Citations:    Fields:    Translation:Humans
    44. Saleem R, Reese JA, George JN. Drug-induced thrombotic microangiopathy: An updated systematic review, 2014-2018. Am J Hematol. 2018 09; 93(9):E241-E243. PMID: 29985540.
      Citations: 9     Fields:    Translation:HumansAnimals
    45. Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Knudtson EJ, Terrell DR, Vesely SK, George JN. Platelet Counts during Pregnancy. N Engl J Med. 2018 Jul 05; 379(1):32-43. PMID: 29972751.
      Citations: 46     Fields:    Translation:Humans
    46. Pishko AM, Misgav M, Cuker A, Cines DB, George JN, Vesely SK, Terrell DR. Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists. J Thromb Thrombolysis. 2018 Jul; 46(1):24-30. PMID: 29582213.
      Citations: 5     Fields:    Translation:Humans
    47. George JN. The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective. Blood Adv. 2018 06 26; 2(12):1510-1516. PMID: 29945940.
      Citations: 12     Fields:    Translation:Humans
    48. George JN. The importance of clinical judgment for the diagnosis of thrombotic thrombocytopenic purpura. Transfusion. 2017 11; 57(11):2558-2561. PMID: 29105831.
      Citations: 2     Fields:    Translation:Humans
    49. George JN, Sandler SA, Stankiewicz J. Management of thrombotic thrombocytopenic purpura without plasma exchange: the Jehovah's Witness experience. Blood Adv. 2017 Nov 14; 1(24):2161-2165. PMID: 29296863.
      Citations: 7     Fields:    
    50. Cataland SR, Kourlas PJ, Yang S, Geyer S, Witkoff L, Wu H, Masias C, George JN, Wu HM. Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura. Blood Adv. 2017 Oct 24; 1(23):2075-2082. PMID: 29296854.
      Citations: 24     Fields:    
    51. Fattah H, Kumar D, George JN, Massey HD, King AL, Friedman KD, Gupta G. Successful kidney transplantation in a patient with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome). Transfusion. 2017 12; 57(12):3058-3062. PMID: 28940540.
      Citations: 2     Fields:    Translation:Humans
    52. Ayanambakkam A, Kremer Hovinga JA, Vesely SK, George JN. Diagnosis of thrombotic thrombocytopenic purpura among patients with ADAMTS13 Activity 10%-20. Am J Hematol. 2017 Nov; 92(11):E644-E646. PMID: 28815685.
      Citations: 4     Fields:    Translation:Humans
    53. Ayanambakkam A, Owens KC, McIntosh JJ, Nester CM, George JN. A postpartum perfect storm. Am J Hematol. 2017 Oct; 92(10):1105-1110. PMID: 28699161.
      Citations: 1     Fields:    Translation:Humans
    54. Reese JA, Peck JD, McIntosh JJ, Vesely SK, George JN. Platelet counts in women with normal pregnancies: A systematic review. Am J Hematol. 2017 Nov; 92(11):1224-1232. PMID: 28631317.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    55. Page EE, Little DJ, Vesely SK, George JN. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients. Am J Kidney Dis. 2017 Nov; 70(5):686-695. PMID: 28780041.
      Citations: 11     Fields:    Translation:Humans
    56. Uhl L, Kiss JE, Malynn E, Terrell DR, Vesely SK, George JN. Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial. Transfusion. 2017 10; 57(10):2532-2538. PMID: 28671324.
      Citations: 10     Fields:    Translation:Humans
    57. Little DJ, Mathias LM, Page EE, Kremer Hovinga JA, Vesely SK, George JN. Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic Purpura. Kidney Int Rep. 2017 Nov; 2(6):1088-1095. PMID: 29270517.
      Citations: 6     
    58. Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015. Blood Adv. 2017 Apr 11; 1(10):590-600. PMID: 29296701.
      Citations: 84     Fields:    
    59. George JN, Morton JM, Liles NW, Nester CM. After the Party's Over. N Engl J Med. 2017 Jan 05; 376(1):74-80. PMID: 28052232.
      Citations: 4     Fields:    Translation:Humans
    60. George JN. Interferon-induced thrombotic microangiopathy. Blood. 2016 12 15; 128(24):2753-2754. PMID: 27979867.
      Citations: 1     Fields:    Translation:Humans
    61. Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura. Blood. 2016 10 27; 128(17):2175-2178. PMID: 27625362.
      Citations: 26     Fields:    Translation:Humans
    62. Terrell DR, Reese J, Branesky D, Lu K, Watson SI, Thachil J, Vesely SK, George JN. Depression in adult patients with primary immune thrombocytopenia. Am J Hematol. 2016 10; 91(10):E462-3. PMID: 27434706.
      Citations: 1     Fields:    Translation:Humans
    63. Morton JM, George JN. Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer. J Oncol Pract. 2016 06; 12(6):523-30. PMID: 27288467.
      Citations: 26     Fields:    Translation:Humans
    64. Page EE, Jiang Y, Terrell DR, Vesely SK, George JN. Long-term outcomes of health-related quality of life following diverse thrombotic microangiopathy syndromes. Am J Hematol. 2016 Jun; 91(4):E278-9. PMID: 26822687.
      Citations: 1     Fields:    Translation:Humans
    65. Epperla N, Hemauer K, Friedman KD, George JN, Foy P. Congenital thrombotic thrombocytopenic purpura related to a novel mutation in ADAMTS13 gene and management during pregnancy. Am J Hematol. 2016 06; 91(6):644-6. PMID: 26822222.
      Citations: 4     Fields:    Translation:HumansCells
    66. Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2016 06 16; 127(24):3092-4. PMID: 27060171.
      Citations: 41     Fields:    Translation:HumansPHPublic Health
    67. Liles NW, Page EE, Liles AL, Vesely SK, Raskob GE, George JN. Diversity and severity of adverse reactions to quinine: A systematic review. Am J Hematol. 2016 May; 91(5):461-6. PMID: 26822544.
      Citations: 16     Fields:    Translation:Humans
    68. George JN. Cobalamin C deficiency-associated thrombotic microangiopathy: uncommon or unrecognised? Lancet. 2015 Sep 05; 386(9997):1012. PMID: 26369475.
      Citations: 5     Fields:    Translation:Humans
    69. Burns LJ, Clayton CP, George JN, Mitchell BS, Gitlin SD. The effect of an intense mentoring program on junior investigators' preparation for a patient-oriented clinical research career. Acad Med. 2015 Aug; 90(8):1061-6. PMID: 26222198.
      Citations: 17     Fields:    Translation:Humans
    70. Tefferi A, Kantarjian H, Rajkumar SV, Baker LH, Abkowitz JL, Adamson JW, Advani RH, Allison J, Antman KH, Bast RC, Bennett JM, Benz EJ, Berliner N, Bertino J, Bhatia R, Bhatia S, Bhojwani D, Blanke CD, Bloomfield CD, Bosserman L, Broxmeyer HE, Byrd JC, Cabanillas F, Canellos GP, Chabner BA, Chanan-Khan A, Cheson B, Clarkson B, Cohn SL, Colon-Otero G, Cortes J, Coutre S, Cristofanilli M, Curran WJ, Daley GQ, DeAngelo DJ, Deeg HJ, Einhorn LH, Erba HP, Esteva FJ, Estey E, Fidler IJ, Foran J, Forman S, Freireich E, Fuchs C, George JN, Gertz MA, Giralt S, Golomb H, Greenberg P, Gutterman J, Handin RI, Hellman S, Hoff PM, Hoffman R, Hong WK, Horowitz M, Hortobagyi GN, Hudis C, Issa JP, Johnson BE, Kantoff PW, Kaushansky K, Khayat D, Khuri FR, Kipps TJ, Kripke M, Kyle RA, Larson RA, Lawrence TS, Levine R, Link MP, Lippman SM, Lonial S, Lyman GH, Markman M, Mendelsohn J, Meropol NJ, Messinger Y, Mulvey TM, O'Brien S, Perez-Soler R, Pollock R, Prchal J, Press O, Radich J, Rai K, Rosenberg SA, Rowe JM, Rugo H, Runowicz CD, Sandmaier BM, Saven A, Schafer AI, Schiffer C, Sekeres MA, Silver RT, Siu LL, Steensma DP, Stewart FM, Stock W, Stone R, Storb R, Strong LC, Tallman MS, Thompson M, Ueno NT, Van Etten RA, Vose JM, Wiernik PH, Winer EP, Younes A, Zelenetz AD, LeMaistre CA. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000. PMID: 26211600.
      Citations: 51     Fields:    Translation:Humans
    71. Han B, Page EE, Stewart LM, Deford CC, Scott JG, Schwartz LH, Perdue JJ, Terrell DR, Vesely SK, George JN. Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura. Am J Hematol. 2015 Aug; 90(8):709-14. PMID: 25975932.
      Citations: 27     Fields:    Translation:Humans
    72. Reese JA, Bougie DW, Curtis BR, Terrell DR, Vesely SK, Aster RH, George JN. Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin. Am J Hematol. 2015 May; 90(5):406-10. PMID: 25639727.
      Citations: 25     Fields:    Translation:Humans
    73. Edgar CE, Terrell DR, Vesely SK, Wren JD, Dozmorov IM, Niewold TB, Brown M, Zhou F, Frank MB, Merrill JT, Kremer Hovinga JA, Lämmle B, James JA, George JN, Farris AD. Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura. PLoS One. 2015; 10(2):e0117614. PMID: 25671313.
      Citations: 2     Fields:    Translation:HumansCells
    74. Lim W, Vesely SK, George JN. The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura. Blood. 2015 Mar 05; 125(10):1526-31. PMID: 25573992.
      Citations: 33     Fields:    Translation:Humans
    75. George JN. Measuring ADAMTS13 activity in patients with suspected thrombotic thrombocytopenic purpura: when, how, and why? Transfusion. 2015 Jan; 55(1):11-3. PMID: 25582234.
      Citations: 6     Fields:    Translation:Humans
    76. George JN, Nester CM, McIntosh JJ. Syndromes of thrombotic microangiopathy associated with pregnancy. Hematology Am Soc Hematol Educ Program. 2015; 2015:644-8. PMID: 26637783.
      Citations: 24     Fields:    Translation:Humans
    77. McClain RS, Terrell DR, Vesely SK, George JN. Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014. Transfusion. 2014 Dec; 54(12):3257-9. PMID: 25496391.
      Citations: 8     Fields:    Translation:Humans
    78. Al-Nouri ZL, Reese JA, Terrell DR, Vesely SK, George JN. Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood. 2015 Jan 22; 125(4):616-8. PMID: 25414441.
      Citations: 117     Fields:    Translation:Humans
    79. George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014 11 06; 371(19):1847-8. PMID: 25372103.
      Citations: 48     Fields:    Translation:Humans
    80. Parekh HD, Reese JA, Cobb PW, George JN. Bone marrow necrosis discovered in a patient with suspected thrombotic thrombocytopenic purpura. Am J Hematol. 2015 Mar; 90(3):264-6. PMID: 25196665.
      Citations: 2     Fields:    Translation:Humans
    81. Khawandanah MO, Weiss SM, Cherry MA, Maymani H, Selby GB, Aster RH, George JN, Holter Chakrabarty JL. Autoimmune hemolytic anemia and thrombocytopenia attributed to an intrauterine contraceptive device. Transfusion. 2015 Mar; 55(3):657-60. PMID: 25208591.
      Citations:    Fields:    Translation:HumansAnimals
    82. George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014 Aug 14; 371(7):654-66. PMID: 25119611.
      Citations: 357     Fields:    Translation:Humans
    83. Little DJ, Reese JA, Vesely SK, George JN. Increased urinary albumin excretion following recovery from thrombotic thrombocytopenic purpura due to acquired ADAMTS13 deficiency. Am J Kidney Dis. 2014 Aug; 64(2):317-8. PMID: 24797525.
      Citations: 6     Fields:    Translation:Humans
    84. George JN, López JA, Konkle BA. N-Acetylcysteine: an old drug, a new insight, a potentially effective treatment for thrombotic thrombocytopenic purpura. Transfusion. 2014 May; 54(5):1205-7. PMID: 24819072.
      Citations: 6     Fields:    Translation:Humans
    85. Lu KH, George JN, Vesely SK, Terrell DR. Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Am J Med Sci. 2014 Mar; 347(3):190-4. PMID: 23462246.
      Citations: 5     Fields:    Translation:Humans
    86. Mirtsching BC, George JN, Aster RH, Curtis BR. Irinotecan-induced immune thrombocytopenia. Am J Med Sci. 2014 Feb; 347(2):167-9. PMID: 24472819.
      Citations: 2     Fields:    Translation:Humans
    87. Jiang Y, McIntosh JJ, Reese JA, Deford CC, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, Knudtson EJ, George JN. Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood. 2014 Mar 13; 123(11):1674-80. PMID: 24398329.
      Citations: 17     Fields:    Translation:Humans
    88. Nokes T, George JN, Vesely SK, Awab A. Pulmonary involvement in patients with thrombotic thrombocytopenic purpura. Eur J Haematol. 2014 Feb; 92(2):156-63. PMID: 24164539.
      Citations: 4     Fields:    Translation:Humans
    89. Reese JA, Nguyen LP, Buchanan GR, Curtis BR, Terrell DR, Vesely SK, George JN. Drug-induced thrombocytopenia in children. Pediatr Blood Cancer. 2013 Dec; 60(12):1975-81. PMID: 24038783.
      Citations: 9     Fields:    Translation:Humans
    90. Thachil J, Salter I, George JN. Complete remission of refractory immune thrombocytopenia (ITP) with a short course of Romiplostim. Eur J Haematol. 2013 Oct; 91(4):376-7. PMID: 23822831.
      Citations: 7     Fields:    Translation:HumansCells
    91. Deford CC, Reese JA, Schwartz LH, Perdue JJ, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, George JN. Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood. 2013 Sep 19; 122(12):2023-9; quiz 2142. PMID: 23838348.
      Citations: 71     Fields:    Translation:HumansCells
    92. Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, Kelton JG. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev. 2013 Jul; 27(3):137-45. PMID: 23845922.
      Citations: 53     Fields:    Translation:HumansCells
    93. Reese JA, Muthurajah DS, Kremer Hovinga JA, Vesely SK, Terrell DR, George JN. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer. 2013 Oct; 60(10):1676-82. PMID: 23729372.
      Citations: 73     Fields:    Translation:HumansCTClinical Trials
    94. George JN, Vesely SK, Woolf SH. Conflicts of interest and clinical recommendations: comparison of two concurrent clinical practice guidelines for primary immune thrombocytopenia developed by different methods. Am J Med Qual. 2014 Jan-Feb; 29(1):53-60. PMID: 23550214.
      Citations: 8     Fields:    Translation:Humans
    95. George JN, Charania RS. Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia. Semin Thromb Hemost. 2013 Mar; 39(2):153-60. PMID: 23390027.
      Citations: 16     Fields:    Translation:Humans
    96. George JN, Vesely SK, Terrell DR, Deford CC, Reese JA, Al-Nouri ZL, Stewart LM, Lu KH, Muthurajah DS. The Oklahoma Thrombotic Thrombocytopenic Purpura-haemolytic Uraemic Syndrome Registry. A model for clinical research, education and patient care. Hamostaseologie. 2013 May 29; 33(2):105-12. PMID: 23364684.
      Citations: 7     Fields:    Translation:Humans
    97. Griffin D, Al-Nouri ZL, Muthurajah D, Ross JR, Ballard RB, Terrell DR, Vesely SK, George JN, Marques MB. First symptoms in patients with thrombotic thrombocytopenic purpura: what are they and when do they occur? Transfusion. 2013 Jan; 53(1):235-7. PMID: 23294213.
      Citations: 8     Fields:    Translation:Humans
    98. Mahabir VK, Ross C, Popovic S, Sur ML, Bourgeois J, Lim W, George JN, Wang G, Cook RJ, Toltl LJ, Nazi I, Kelton JG, Arnold DM. A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia. Eur J Haematol. 2013 Feb; 90(2):121-6. PMID: 23140198.
      Citations: 9     Fields:    Translation:HumansCells
    99. George JN, Chen Q, Deford CC, Al-Nouri Z. Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency. J Clin Apher. 2012; 27(6):302-11. PMID: 22927184.
      Citations: 14     Fields:    Translation:Humans
    100. Al-Nouri ZL, George JN. Drug-induced thrombocytopenia: an updated systematic review, 2012. Drug Saf. 2012 Aug 01; 35(8):693-4. PMID: 22762135.
      Citations: 1     Fields:    Translation:Humans
    101. George JN. Forecasting the future for patients with hereditary TTP. Blood. 2012 Jul 12; 120(2):243-4. PMID: 22791774.
      Citations:    Fields:    
    102. George JN, Vesely SK. A seasonal association of incident cases of thrombotic thrombocytopenic purpura was not observed in the Oklahoma TTP-HUS Registry. Transfusion. 2012 Jul; 52(7):1593-4; author reply 1594-5. PMID: 22780896.
      Citations:    Fields:    Translation:Humans
    103. Wahl PM, Bohn RL, Terrell DR, George JN, Ewenstein B. Health care utilization of patients diagnosed with idiopathic thrombotic thrombocytopenic purpura in a commercially insured population in the United States. Transfusion. 2012 Jul; 52(7 Pt 2):1614-21. PMID: 22780943.
      Citations: 2     Fields:    Translation:Humans
    104. Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol. 2012 Sep; 87(9):843-7. PMID: 22718340.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    105. Terrell DR, Beebe LA, Neas BR, Vesely SK, Segal JB, George JN. Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol. 2012 Sep; 87(9):848-52. PMID: 22674643.
      Citations: 25     Fields:    Translation:Humans
    106. Som S, Deford CC, Kaiser ML, Terrell DR, Kremer Hovinga JA, Lämmle B, George JN, Vesely SK. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion. 2012 Dec; 52(12):2525-32; quiz 2524. PMID: 22501034.
      Citations: 19     Fields:    Translation:Humans
    107. George JN. Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura. Am J Hematol. 2012 May; 87 Suppl 1:S88-91. PMID: 22407740.
      Citations: 13     Fields:    Translation:Humans
    108. George JN. Sequence of treatments for adults with primary immune thrombocytopenia. Am J Hematol. 2012 May; 87 Suppl 1:S12-5. PMID: 22389032.
      Citations: 1     Fields:    Translation:Humans
    109. Tarr PI, Sadler JE, Chandler WL, George JN, Tsai HM. Should all adult patients with diarrhoea-associated HUS receive plasma exchange? Lancet. 2012 Feb 11; 379(9815):516; author reply 516-7. PMID: 22325653.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    110. George JN, Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B. Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. Presse Med. 2012 Mar; 41(3 Pt 2):e177-88. PMID: 22244728.
      Citations: 10     Fields:    Translation:Humans
    111. George JN, Al-Nouri ZL. Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes. Hematology Am Soc Hematol Educ Program. 2012; 2012:604-9. PMID: 23233641.
      Citations: 18     Fields:    Translation:Humans
    112. Froehlich-Zahnd R, George JN, Vesely SK, Terrell DR, Aboulfatova K, Dong JF, Luken BM, Voorberg J, Budde U, Sulzer I, Lämmle B, Kremer Hovinga JA. Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica. 2012 Feb; 97(2):297-303. PMID: 21993669.
      Citations: 24     Fields:    Translation:HumansCells
    113. George JN. Children with ITP: looking beyond the platelet count. Pediatr Blood Cancer. 2012 Mar; 58(3):323-4. PMID: 21898785.
      Citations:    Fields:    Translation:Humans
    114. Booth KK, Terrell DR, Vesely SK, George JN. Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol. 2011 Sep; 86(9):743-51. PMID: 21850657.
      Citations: 34     Fields:    Translation:Humans
    115. George JN. Systemic malignancies as a cause of unexpected microangiopathic hemolytic anemia and thrombocytopenia. Oncology (Williston Park). 2011 Sep; 25(10):908-14. PMID: 22010388.
      Citations: 29     Fields:    Translation:Humans
    116. Nguyen L, Reese J, George JN. Drug-induced thrombocytopenia: an updated systematic review, 2010. Drug Saf. 2011 May 01; 34(5):437-8. PMID: 21661269.
      Citations: 3     Fields:    Translation:Humans
    117. Terrell DR, Motto DG, Kremer Hovinga JA, Lämmle B, George JN, Vesely SK. Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. Transfusion. 2011 Oct; 51(10):2237-43. PMID: 21470236.
      Citations: 11     Fields:    Translation:Humans
    118. Newton JL, Reese JA, Watson SI, Vesely SK, Bolton-Maggs PH, George JN, Terrell DR. Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2011 May; 86(5):420-9. PMID: 21323737.
      Citations: 26     Fields:    Translation:Humans
    119. George JN. Management of immune thrombocytopenia--something old, something new. N Engl J Med. 2010 Nov 11; 363(20):1959-61. PMID: 21067388.
      Citations: 5     Fields:    Translation:Humans
    120. Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B, George JN. Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. Am J Hematol. 2010 Nov; 85(11):844-7. PMID: 20799358.
      Citations: 16     Fields:    Translation:Humans
    121. George JN. ADAMTS13 Alone. Blood. 2010 Sep 23; 116(12):2003-4. PMID: 20864586.
      Citations: 2     Fields:    
    122. George JN. How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood. 2010 Nov 18; 116(20):4060-9. PMID: 20686117.
      Citations: 124     Fields:    Translation:Humans
    123. Reese JA, Li X, Hauben M, Aster RH, Bougie DW, Curtis BR, George JN, Vesely SK. Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood. 2010 Sep 23; 116(12):2127-33. PMID: 20530792.
      Citations: 42     Fields:    Translation:HumansCells
    124. Royer DJ, George JN, Terrell DR. Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages. Eur J Haematol. 2010 May; 84(5):421-9. PMID: 20525061.
      Citations: 13     Fields:    Translation:Humans
    125. Wahl PM, Terrell DR, George JN, Rodgers JK, Uhl L, Cataland S, Bohn RL. Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially-insured population. Thromb Haemost. 2010 Jun; 103(6):1203-9. PMID: 20352159.
      Citations: 1     Fields:    Translation:Humans
    126. Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol. 2010 Mar; 85(3):174-80. PMID: 20131303.
      Citations: 145     Fields:    Translation:HumansPHPublic Health
    127. Slichter SJ, Kaufman RM, Assmann SF, McCullough J, Triulzi DJ, Strauss RG, Gernsheimer TB, Ness PM, Brecher ME, Josephson CD, Konkle BA, Woodson RD, Ortel TL, Hillyer CD, Skerrett DL, McCrae KR, Sloan SR, Uhl L, George JN, Aquino VM, Manno CS, McFarland JG, Hess JR, Leissinger C, Granger S. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med. 2010 Feb 18; 362(7):600-13. PMID: 20164484.
      Citations: 137     Fields:    Translation:Humans
    128. Viswanathan S, Rovin BH, Shidham GB, Raman SV, Weinberg M, Patricia A, George JN, Wu HM, Cataland SR. Long-term, sub-clinical cardiac and renal complications in patients with multiple relapses of thrombotic thrombocytopenic purpura. Br J Haematol. 2010 May; 149(4):623-5. PMID: 20148878.
      Citations: 4     Fields:    Translation:Humans
    129. Rousan TA, Aldoss IT, Cowley BD, Curtis BR, Bougie DW, Aster RH, George JN. Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia. Am J Hematol. 2010 Jan; 85(1):71-4. PMID: 19802882.
      Citations: 19     Fields:    Translation:Humans
    130. Kremer Hovinga JA, Vesely SK, Terrell DR, Lämmle B, George JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2010 Feb 25; 115(8):1500-11; quiz 1662. PMID: 20032506.
      Citations: 158     Fields:    Translation:Humans
    131. Cataland SR, Yang SB, Witkoff L, Kraut EH, Lin S, George JN, Wu HM. Demographic and ADAMTS13 biomarker data as predictors of early recurrences of idiopathic thrombotic thrombocytopenic purpura. Eur J Haematol. 2009 Dec 01; 83(6):559-64. PMID: 19674080.
      Citations: 7     Fields:    Translation:Humans
    132. Guidry JA, Watson S, George JN, Vesely SK, Terrell DR. Addendum to corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives. Eur J Haematol. 2009 Nov; 83(5):497-8. PMID: 19614752.
      Citations: 1     Fields:    Translation:Humans
    133. Bose P, Hussein KK, Terrell DR, Berger D, Rice L, George JN. Successful treatment of cyclic thrombocytopenia with thrombopoietin-mimetic agents: a report of two patients. Am J Hematol. 2009 Jul; 84(7):459-61. PMID: 19484732.
      Citations: 4     Fields:    Translation:Humans
    134. George JN. Definition, diagnosis and treatment of immune thrombocytopenic purpura. Haematologica. 2009 Jun; 94(6):759-62. PMID: 19483153.
      Citations: 9     Fields:    Translation:HumansCells
    135. Terrell DR, Beebe LA, George JN, Vesely SK, Mold JW. Referral of patients with thrombocytopenia from primary care clinicians to hematologists. Blood. 2009 Apr 23; 113(17):4126-7. PMID: 19389893.
      Citations: 4     Fields:    Translation:Humans
    136. Benjamin M, Terrell DR, Vesely SK, Voskuhl GW, Dezube BJ, Kremer Hovinga JA, Lämmle B, George JN. Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis. 2009 Apr 15; 48(8):1129-37. PMID: 19275493.
      Citations: 10     Fields:    Translation:Humans
    137. Guidry JA, George JN, Vesely SK, Kennison SM, Terrell DR. Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol. 2009 Sep; 83(3):175-82. PMID: 19374704.
      Citations: 22     Fields:    Translation:Humans
    138. Dimond A, George JN, Hastings C. Severe vitamin B-12 deficiency in a child mimicking thrombotic thrombocytopenic purpura. Pediatr Blood Cancer. 2009 Mar; 52(3):420-2. PMID: 18985742.
      Citations: 6     Fields:    Translation:Humans
    139. Kennedy AS, Lewis QF, Scott JG, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, George JN. Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jun; 49(6):1092-101. PMID: 19222817.
      Citations: 25     Fields:    Translation:Humans
    140. Swisher KK, Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B, George JN. Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion. 2009 May; 49(5):873-87. PMID: 19210323.
      Citations: 20     Fields:    Translation:Humans
    141. George JN. ADAMTS13: what it does, how it works, and why it's important. Transfusion. 2009 Feb; 49(2):196-8. PMID: 19389203.
      Citations: 1     Fields:    Translation:HumansCells
    142. Nguyen L, Terrell DR, Duvall D, Vesely SK, George JN. Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008. Transfusion. 2009 Feb; 49(2):392-4. PMID: 19389220.
      Citations: 10     Fields:    Translation:HumansCells
    143. George JN. The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: evaluation, management, and long-term outcomes experience of the Oklahoma TTP-HUS Registry, 1989-2007. Kidney Int Suppl. 2009 Feb; (112):S52-4. PMID: 19180137.
      Citations: 11     Fields:    Translation:Humans
    144. George JN. The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (Experience of The Oklahoma TTP-HUS Registry, 1989-2007). Kidney Int Suppl. 2009 Feb; (112):S8-S10. PMID: 19180141.
      Citations: 12     Fields:    Translation:HumansCells
    145. Swisher KK, Li X, Vesely SK, George JN. Drug-induced thrombocytopenia: an updated systematic review, 2008. Drug Saf. 2009; 32(1):85-6. PMID: 19132808.
      Citations: 6     Fields:    Translation:Humans
    146. George JN, Aster RH. Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematology Am Soc Hematol Educ Program. 2009; 153-8. PMID: 20008194.
      Citations: 83     Fields:    Translation:Humans
    147. Cataland SR, Jin M, Lin S, Kraut EH, George JN, Wu HM. Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura. Am J Hematol. 2008 Dec; 83(12):911-5. PMID: 18821711.
      Citations: 10     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    148. Fujimura Y, Matsumoto M, Kokame K, Isonishi A, Soejima K, Akiyama N, Tomiyama J, Natori K, Kuranishi Y, Imamura Y, Inoue N, Higasa S, Seike M, Kozuka T, Hara M, Wada H, Murata M, Ikeda Y, Miyata T, George JN. Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. Br J Haematol. 2009 Mar; 144(5):742-54. PMID: 19055667.
      Citations: 27     Fields:    Translation:Humans
    149. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009 Mar 12; 113(11):2386-93. PMID: 19005182.
      Citations: 702     Fields:    Translation:Humans
    150. George JN, Mathias SD, Go RS, Guo M, Henry DH, Lyons R, Redner RL, Rice L, Schipperus MR. Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. Br J Haematol. 2009 Feb; 144(3):409-15. PMID: 19016720.
      Citations: 40     Fields:    Translation:Humans
    151. Lewis QF, Lanneau MS, Mathias SD, Terrell DR, Vesely SK, George JN. Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jan; 49(1):118-24. PMID: 18954401.
      Citations: 19     Fields:    Translation:Humans
    152. George JN, Terrell DR. Novel thrombopoietic agents: a new era for management of patients with thrombocytopenia. Haematologica. 2008 Oct; 93(10):1445-9. PMID: 18827261.
      Citations: 2     Fields:    Translation:HumansCells
    153. George JN. Clinical insights from observations on ADAMTS13 deficiency in liver cirrhosis. Thromb Haemost. 2008 Jun; 99(6):987-8. PMID: 18521495.
      Citations: 1     Fields:    Translation:HumansCells
    154. Crowther MA, George JN. Thrombotic thrombocytopenic purpura: 2008 update. Cleve Clin J Med. 2008 May; 75(5):369-75. PMID: 18556880.
      Citations: 8     Fields:    Translation:Humans
    155. George JN. Congenital thrombotic thrombocytopenic purpura: Lessons for recognition and management of rare syndromes. Pediatr Blood Cancer. 2008 May; 50(5):947-8. PMID: 18360884.
      Citations: 3     Fields:    Translation:Humans
    156. Karpac CA, Li X, Terrell DR, Kremer Hovinga JA, Lämmle B, Vesely SK, George JN. Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol. 2008 May; 141(5):696-707. PMID: 18422775.
      Citations: 14     Fields:    Translation:HumansCells
    157. Mathias SD, Gao SK, Miller KL, Cella D, Snyder C, Turner R, Wu A, Bussel JB, George JN, McMillan R, Wysocki DK, Nichol JL. Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes. 2008 Feb 08; 6:13. PMID: 18261217.
      Citations: 29     Fields:    Translation:Humans
    158. Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008 Feb 02; 371(9610):395-403. PMID: 18242413.
      Citations: 235     Fields:    Translation:Humans
    159. Lämmle B, Kremer Hovinga JA, George JN. Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease. Haematologica. 2008 Feb; 93(2):172-7. PMID: 18245649.
      Citations: 6     Fields:    Translation:HumansCells
    160. McMillan R, Bussel JB, George JN, Lalla D, Nichol JL. Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol. 2008 Feb; 83(2):150-4. PMID: 17722072.
      Citations: 39     Fields:    Translation:Humans
    161. George JN, Kremer Hovinga JA, Terrell DR, Vesely SK, Lämmle B. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection. Eur J Haematol. 2008 Apr; 80(4):277-86. PMID: 18221388.
      Citations: 5     Fields:    Translation:Humans
    162. Siami K, Kojouri K, Swisher KK, Selby GB, George JN, Laszik ZG. Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation. 2008 Jan 15; 85(1):22-8. PMID: 18192907.
      Citations: 34     Fields:    Translation:Humans
    163. George JN, Terrell DR, Swisher KK, Vesely SK. Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry. J Clin Apher. 2008; 23(4):129-37. PMID: 18618590.
      Citations: 14     Fields:    Translation:Humans
    164. Ambadwar P, Duvall D, Wolf NJ, Terrell DR, Vesely SK, George JN. Support groups for patients who have recovered from thrombotic thrombocytopenic purpura. J Clin Apher. 2008; 23(5):168-9. PMID: 18785649.
      Citations: 6     Fields:    Translation:Humans
    165. Hawkins BM, Abu-Fadel M, Vesely SK, George JN. Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion. 2008 Feb; 48(2):382-92. PMID: 18028268.
      Citations: 38     Fields:    Translation:Humans
    166. Nguyen L, Li X, Duvall D, Terrell DR, Vesely SK, George JN. Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006. Transfusion. 2008 Feb; 48(2):349-57. PMID: 18028271.
      Citations: 13     Fields:    Translation:Humans
    167. Karpac CA, Lee A, Kunnel BS, Bamgbola OF, Vesely SK, George JN. Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005. J Okla State Med Assoc. 2007 Nov; 100(11):429-33. PMID: 18183860.
      Citations: 2     Fields:    Translation:HumansCells
    168. Cataland SR, Jin M, Lin S, Kennedy MS, Kraut EH, George JN, Wu HM. Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity. Br J Haematol. 2007 Nov; 139(3):486-93. PMID: 17910638.
      Citations: 18     Fields:    Translation:Humans
    169. Johnson KK, Duvall D, Gilcher RO, Smith JW, Forsberg JE, Terrell DR, Vesely SK, George JN. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a community service. J Okla State Med Assoc. 2007 Jul; 100(7):273-8. PMID: 17896615.
      Citations: 1     Fields:    Translation:Humans
    170. Swisher KK, Doan JT, Vesely SK, Kwaan HC, Kim B, Lämmle B, Kremer Hovinga JA, George JN. Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica. 2007 Jul; 92(7):936-43. PMID: 17606444.
      Citations: 31     Fields:    Translation:Humans
    171. Feldman M, Bruno T, Chong YC, Borstad G, Wild C, Lopez JD, George JN. Bilateral nephrectomy for treatment resistant systemic lupus erythematosis and thrombotic thrombocytopenic purpura: a case report. Am J Hematol. 2007 Jun; 82(6):496-7. PMID: 17154378.
      Citations: 2     Fields:    Translation:Humans
    172. George JN, Vesely SK, James JA. Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus. South Med J. 2007 May; 100(5):512-4. PMID: 17534089.
      Citations: 14     Fields:    Translation:Humans
    173. Mathias SD, Bussel JB, George JN, McMillan R, Okano GJ, Nichol JL. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial. Clin Ther. 2007 May; 29(5):950-962. PMID: 17697914.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    174. George JN. Evaluation and management of patients with thrombotic thrombocytopenic purpura. J Intensive Care Med. 2007 Mar-Apr; 22(2):82-91. PMID: 17456728.
      Citations: 5     Fields:    Translation:Humans
    175. Kojouri K, George JN. Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation. Curr Opin Oncol. 2007 Mar; 19(2):148-54. PMID: 17272988.
      Citations: 13     Fields:    Translation:Humans
    176. Mathias SD, Bussel JB, George JN, McMillan R, Okano GJ, Nichol JL. A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation. Health Qual Life Outcomes. 2007 Feb 22; 5:11. PMID: 17316442.
      Citations: 14     Fields:    Translation:Humans
    177. Francis KK, Kalyanam N, Terrell DR, Vesely SK, George JN. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist. 2007 Jan; 12(1):11-9. PMID: 17227897.
      Citations: 34     Fields:    Translation:HumansCells
    178. Ruutu T, Barosi G, Benjamin RJ, Clark RE, George JN, Gratwohl A, Holler E, Iacobelli M, Kentouche K, Lämmle B, Moake JL, Richardson P, Socié G, Zeigler Z, Niederwieser D, Barbui T. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica. 2007 Jan; 92(1):95-100. PMID: 17229640.
      Citations: 108     Fields:    Translation:Humans
    179. Li X, Swisher KK, Vesely SK, George JN. Drug-induced thrombocytopenia: an updated systematic review, 2006. Drug Saf. 2007; 30(2):185-6. PMID: 17253882.
      Citations: 4     Fields:    Translation:Humans
    180. Cataland SR, Jin M, Ferketich AK, Kennedy MS, Kraut EH, George JN, Wu HM. An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura. Br J Haematol. 2007 Jan; 136(1):146-9. PMID: 17069579.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    181. Bussel JB, Kuter DJ, George JN, McMillan R, Aledort LM, Conklin GT, Lichtin AE, Lyons RM, Nieva J, Wasser JS, Wiznitzer I, Kelly R, Chen CF, Nichol JL. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med. 2006 Oct 19; 355(16):1672-81. PMID: 17050891.
      Citations: 120     Fields:    Translation:HumansCTClinical Trials
    182. George JN. Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost. 2006 Aug; 4(8):1664-72. PMID: 16879206.
      Citations: 31     Fields:    Translation:HumansCells
    183. George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006 May 04; 354(18):1927-35. PMID: 16672704.
      Citations: 108     Fields:    Translation:Humans
    184. Kamble RT, Selby GB, Mims M, Kharfan-Dabaja MA, Ozer H, George JN. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006 May; 12(5):506-10. PMID: 16635785.
      Citations: 18     Fields:    Translation:Humans
    185. George JN, Woodson RD, Kiss JE, Kojouri K, Vesely SK. Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher. 2006 Apr; 21(1):49-56. PMID: 16619232.
      Citations: 22     Fields:    Translation:Humans
    186. Howard MA, Williams LA, Terrell DR, Duvall D, Vesely SK, George JN. Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion. 2006 Jan; 46(1):154-6. PMID: 16398746.
      Citations: 22     Fields:    Translation:Humans
    187. George JN. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clin Adv Hematol Oncol. 2005 Aug; 3(8):627-32. PMID: 16167049.
      Citations: 3     Fields:    Translation:HumansCells
    188. Terrell DR, Williams LA, Vesely SK, Lämmle B, Hovinga JA, George JN. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost. 2005 Jul; 3(7):1432-6. PMID: 15978100.
      Citations: 67     Fields:    Translation:Humans
    189. George JN. ADAMTS13, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. Curr Hematol Rep. 2005 May; 4(3):167-9. PMID: 15865866.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    190. George JN, Shattil SJ. Letter to authors and readers regarding the new NIH policy on public access. Blood. 2005 May 15; 105(10):3767. PMID: 15817680.
      Citations:    Fields:    Translation:Humans
    191. Terrell DR, Johnson KK, Vesely SK, George JN. Is immune thrombocytopenic purpura less common among black Americans? Blood. 2005 Feb 01; 105(3):1368-9. PMID: 15659620.
      Citations: 2     Fields:    Translation:Humans
    192. Kojouri K, George JN. Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura. Int J Hematol. 2005 Feb; 81(2):119-25. PMID: 15765779.
      Citations: 6     Fields:    Translation:Humans
    193. George JN. Tibor Greenwalt Award. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a program for patient care, education and research. Transfusion. 2004 Sep; 44(9):1384-92. PMID: 15318866.
      Citations: 9     Fields:    Translation:Humans
    194. Vesely SK, Li X, McMinn JR, Terrell DR, George JN. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion. 2004 Aug; 44(8):1149-58. PMID: 15265118.
      Citations: 16     Fields:    Translation:Humans
    195. Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004 Nov 01; 104(9):2623-34. PMID: 15217831.
      Citations: 154     Fields:    Translation:Humans
    196. George JN, Vesely SK. How can we provide the best care for our patients with immune thrombocytopenic pupura? Mayo Clin Proc. 2004 Apr; 79(4):456-7. PMID: 15065609.
      Citations: 2     Fields:    Translation:Humans
    197. George JN. For low platelets, how low is dangerous? Cleve Clin J Med. 2004 Apr; 71(4):277-8. PMID: 15117166.
      Citations: 2     Fields:    Translation:Humans
    198. Bolton-Maggs P, Tarantino MD, Buchanan GR, Bussel JB, George JN. The child with immune thrombocytopenic purpura: is pharmacotherapy or watchful waiting the best initial management? A panel discussion from the 2002 meeting of the American Society of Pediatric Hematology/Oncology. J Pediatr Hematol Oncol. 2004 Feb; 26(2):146-51. PMID: 14767210.
      Citations: 3     Fields:    Translation:Humans
    199. George JN, Li X, McMinn JR, Terrell DR, Vesely SK, Selby GB. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion. 2004 Feb; 44(2):294-304. PMID: 14962323.
      Citations: 57     Fields:    Translation:Humans
    200. Vesely SK, Perdue JJ, Rizvi MA, Terrell DR, George JN. Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med. 2004 Jan 20; 140(2):112-20. PMID: 14734334.
      Citations: 20     Fields:    Translation:Humans
    201. Lämmle B, George JN. Thrombotic thrombocytopenic purpura: advances in pathophysiology, diagnosis, and treatment--introduction. Semin Hematol. 2004 Jan; 41(1):1-3. PMID: 14727253.
      Citations: 5     Fields:    Translation:Humans
    202. George JN, Vesely SK, Terrell DR. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS. Semin Hematol. 2004 Jan; 41(1):60-7. PMID: 14727260.
      Citations: 19     Fields:    Translation:Humans
    203. George JN. Idiopathic thrombocytopenic purpura in adults: current issues for pathogenesis, diagnosis and management. Hematol J. 2004; 5 Suppl 3:S12-4. PMID: 15190270.
      Citations: 1     Fields:    Translation:Humans
    204. George JN. Thrombotic thrombocytopenic purpura: a syndrome that keeps evolving. J Clin Apher. 2004; 19(2):63-5. PMID: 15274197.
      Citations: 1     Fields:    Translation:Humans
    205. Adams JR, Elting LS, Lyman GH, George JN, Lembersky BC, Armitage JO, Demetri GD, Bennett CL. Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries. Am J Med. 2004 Jan 01; 116(1):28-34. PMID: 14706663.
      Citations: 6     Fields:    Translation:Humans
    206. Sadler JE, Moake JL, Miyata T, George JN. Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2004; 407-23. PMID: 15561695.
      Citations: 67     Fields:    Translation:Humans
    207. George JN, Raskob GE, Vesely SK, Moore D, Lyons RM, Cobos E, Towell BL, Klug P, Guthrie TH. Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care. Am J Hematol. 2003 Nov; 74(3):161-9. PMID: 14587042.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    208. George JN. The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol. 2003 Sep; 10(5):339-44. PMID: 12913787.
      Citations: 40     Fields:    Translation:Humans
    209. George JN. Idiopathic thrombocytopenic purpura: current issues for pathogenesis, diagnosis, and management in children and adults. Curr Hematol Rep. 2003 Sep; 2(5):381-7. PMID: 12932309.
      Citations:    Fields:    Translation:Humans
    210. George JN, Vesely SK. Immune thrombocytopenic purpura--let the treatment fit the patient. N Engl J Med. 2003 Aug 28; 349(9):903-5. PMID: 12944577.
      Citations: 2     Fields:    Translation:Humans
    211. McMinn JR, Cohen S, Moore J, Lilly S, Parkhurst J, Tarantino MD, Terrell DR, George JN. Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept. Am J Hematol. 2003 Jun; 73(2):135-40. PMID: 12749017.
      Citations: 11     Fields:    Translation:Humans
    212. Vesely SK, George JN, Lämmle B, Studt JD, Alberio L, El-Harake MA, Raskob GE. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003 Jul 01; 102(1):60-8. PMID: 12637323.
      Citations: 142     Fields:    Translation:Humans
    213. McMinn JR, Thomas IA, Terrell DR, Duvall D, Vesely SK, George JN. Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a study of 78 additional patients. Transfusion. 2003 Mar; 43(3):415-6. PMID: 12675731.
      Citations: 9     Fields:    Translation:Humans
    214. Vesely SK, Buchanan GR, Adix L, George JN, Cohen AR, Blanchette VS, Kühne T. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol. 2003 Feb; 25(2):130-3. PMID: 12571464.
      Citations: 6     Fields:    Translation:Humans
    215. George JN, Vesely SK. Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community. Ann Intern Med. 2003 Jan 21; 138(2):152-3. PMID: 12529099.
      Citations: 1     Fields:    Translation:Humans
    216. Howard MA, Duvall D, Terrell DR, Christopher AT, Thomas I, Holloway N, Vesely SK, George JN. A support group for patients who have recovered from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): The six-year experience of the Oklahoma TTP-HUS Study Group. J Clin Apher. 2003; 18(1):16-20. PMID: 12717788.
      Citations: 8     Fields:    Translation:Humans
    217. Howard MA, Hibbard AB, Terrell DR, Medina PJ, Vesely SK, George JN. Quinine allergy causing acute severe systemic illness: report of 4 patients manifesting multiple hematologic, renal, and hepatic abnormalities. Proc (Bayl Univ Med Cent). 2003 Jan; 16(1):21-6. PMID: 16278718.
      Citations: 3     
    218. Jafari M, Forsberg J, Gilcher RO, Smith JW, Crutcher JM, McDermott M, Brown BR, George JN. Salmonella sepsis caused by a platelet transfusion from a donor with a pet snake. N Engl J Med. 2002 Oct 03; 347(14):1075-8. PMID: 12362008.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    219. George JN. Idiopathic thrombocytopenic purpura and myelodysplastic syndrome: distinct entities or overlapping syndromes? Leuk Res. 2002 Sep; 26(9):789-90. PMID: 12127551.
      Citations: 1     Fields:    Translation:HumansCells
    220. Zondor SD, George JN, Medina PJ. Treatment of drug-induced thrombocytopenia. Expert Opin Drug Saf. 2002 Jul; 1(2):173-80. PMID: 12904151.
      Citations: 2     Fields:    Translation:Humans
    221. George JN. Initial management of adults with idiopathic (immune) thrombocytopenic purpura. Blood Rev. 2002 Mar; 16(1):37-8. PMID: 11913992.
      Citations: 2     Fields:    Translation:Humans
    222. George JN, Sadler JE, Lämmle B. Platelets: thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2002; 315-34. PMID: 12446430.
      Citations: 7     Fields:    Translation:HumansCells
    223. Kojouri K, Vesely SK, George JN. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes. Ann Intern Med. 2001 Dec 18; 135(12):1047-51. PMID: 11747383.
      Citations: 22     Fields:    Translation:Humans
    224. George JN, Vesely SK. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: diagnosis and treatment. Cleve Clin J Med. 2001 Oct; 68(10):857-8, 860, 863-4 passim. PMID: 11596624.
      Citations: 3     Fields:    Translation:Humans
    225. Medina PJ, Sipols JM, George JN. Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol. 2001 Sep; 8(5):286-93. PMID: 11604563.
      Citations: 41     Fields:    Translation:Humans
    226. Roy V, Rizvi MA, Vesely SK, George JN. Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant. 2001 Mar; 27(6):641-6. PMID: 11319595.
      Citations: 16     Fields:    Translation:Humans
    227. McMinn JR, George JN. Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy. J Clin Apher. 2001; 16(4):202-9. PMID: 11835417.
      Citations: 18     Fields:    Translation:Humans
    228. Perdue JJ, Chandler LK, Vesely SK, Duvall DS, Gilcher RO, Smith JW, George JN. Unintentional platelet removal by plasmapheresis. J Clin Apher. 2001; 16(2):55-60. PMID: 11746529.
      Citations: 4     Fields:    Translation:HumansCells
    229. Kojouri K, Perdue JJ, Medina PJ, George JN. Occult quinine-induced thrombocytopenia. J Okla State Med Assoc. 2000 Nov; 93(11):519-21. PMID: 11126885.
      Citations: 11     Fields:    Translation:Humans
    230. George JN. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood. 2000 Aug 15; 96(4):1223-9. PMID: 10942361.
      Citations: 44     Fields:    Translation:Humans
    231. Rizvi MA, Vesely SK, George JN, Chandler L, Duvall D, Smith JW, Gilcher RO. Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome. Transfusion. 2000 Aug; 40(8):896-901. PMID: 10960513.
      Citations: 23     Fields:    Translation:Humans
    232. George JN, Kojouri K, Perdue JJ, Vesely SK. Management of patients with chronic, refractory idiopathic thrombocytopenic purpura. Semin Hematol. 2000 Jul; 37(3):290-8. PMID: 10942223.
      Citations: 9     Fields:    Translation:Humans
    233. George JN. Platelets. Lancet. 2000 Apr 29; 355(9214):1531-9. PMID: 10801186.
      Citations: 116     Fields:    Translation:HumansCells
    234. Birdwell BG, Raskob GE, Whitsett TL, Durica SS, Comp PC, George JN, Tytle TL, Owen WL, McKee PA. Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: clinical implications of the site of vein noncompressibility. Arch Intern Med. 2000 Feb 14; 160(3):309-13. PMID: 10668832.
      Citations: 6     Fields:    Translation:Humans
    235. George JN. Treatment options for chronic idiopathic (immune) thrombocytopenic purpura. Semin Hematol. 2000 Jan; 37(1 Suppl 1):31-4. PMID: 10676922.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    236. Vesely S, Buchanan GR, Cohen A, Raskob G, George J. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists. J Pediatr Hematol Oncol. 2000 Jan-Feb; 22(1):55-61. PMID: 10695823.
      Citations: 8     Fields:    Translation:Humans
    237. Leach JW, Hussein KK, George JN. Acquired pure megakaryocytic aplasia report of two cases with long-term responses to antithymocyte globulin and cyclosporine. Am J Hematol. 1999 Oct; 62(2):115-7. PMID: 10577280.
      Citations: 4     Fields:    Translation:HumansCells
    238. Rizvi MA, Shah SR, Raskob GE, George JN. Drug-induced thrombocytopenia. Curr Opin Hematol. 1999 Sep; 6(5):349-53. PMID: 10468152.
      Citations: 5     Fields:    Translation:Humans
    239. George JN, Woolf SH, Raskob GE. The evidence-based analysis of treatment for chronic myeloid leukemia: An introduction to its methods and clinical implications. Blood. 1999 Sep 01; 94(5):1515-6. PMID: 10477675.
      Citations:    Fields:    Translation:Humans
    240. Leach JW, Pham T, Diamandidis D, George JN. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) following treatment with deoxycoformycin in a patient with cutaneous T-cell lymphoma (Sezary syndrome): A case report. Am J Hematol. 1999 Aug; 61(4):268-70. PMID: 10440915.
      Citations: 8     Fields:    Translation:Humans
    241. George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, Vondracek T. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med. 1998 Dec 01; 129(11):886-90. PMID: 9867731.
      Citations: 125     Fields:    Translation:Humans
    242. George JN, Raskob GE. Idiopathic thrombocytopenic purpura: diagnosis and management. Am J Med Sci. 1998 Aug; 316(2):87-93. PMID: 9704662.
      Citations: 4     Fields:    Translation:Humans
    243. George JN, Woolf SH, Raskob GE. Idiopathic thrombocytopenic purpura: a guideline for diagnosis and management of children and adults. American Society of Hematology. Ann Med. 1998 Feb; 30(1):38-44. PMID: 9556088.
      Citations: 5     Fields:    Translation:Humans
    244. George JN, Raskob GE. Idiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and diagnosis in children and adults. Semin Hematol. 1998 Jan; 35(1 Suppl 1):5-8. PMID: 9523743.
      Citations: 3     Fields:    Translation:Humans
    245. Birdwell BG, Raskob GE, Whitsett TL, Durica SS, Comp PC, George JN, Tytle TL, McKee PA. The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med. 1998 Jan 01; 128(1):1-7. PMID: 9424975.
      Citations: 36     Fields:    Translation:Humans
    246. George JN, Gilcher RO, Smith JW, Chandler L, Duvall D, Ellis C. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: diagnosis and management. J Clin Apher. 1998; 13(3):120-5. PMID: 9828022.
      Citations: 8     Fields:    Translation:Humans
    247. George JN, Raskob GE. Clinical decisions in idiopathic thrombocytopenic purpura. Hosp Pract (1995). 1997 Sep 15; 32(9):159-60, 163-6, 169-70, passim. PMID: 9307602.
      Citations:    Fields:    Translation:Humans
    248. Harrison P, Downs T, Friese P, Wolf R, George JN, Burstein SA. Inhibition of the acute-phase response in vivo by anti-gp130 monoclonal antibodies. Br J Haematol. 1996 Dec; 95(3):443-51. PMID: 8943882.
      Citations: 2     Fields:    Translation:AnimalsCells
    249. George JN. Diagnosis, clinical course, and management of idiopathic thrombocytopenic purpura. Curr Opin Hematol. 1996 Sep; 3(5):335-40. PMID: 9372098.
      Citations: 3     Fields:    Translation:Humans
    250. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996 Jul 01; 88(1):3-40. PMID: 8704187.
      Citations: 230     Fields:    Translation:HumansPHPublic Health
    251. Heilmann E, Hynes LA, Burstein SA, George JN, Dale GL. Fluorescein derivatization of fibrinogen for flow cytometric analysis of fibrinogen binding to platelets. Cytometry. 1994 Dec 01; 17(4):287-93. PMID: 7875035.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    252. George JN, el-Harake MA, Raskob GE. Chronic idiopathic thrombocytopenic purpura. N Engl J Med. 1994 Nov 03; 331(18):1207-11. PMID: 7935660.
      Citations: 35     Fields:    Translation:Humans
    253. Peng J, Friese P, George JN, Dale GL, Burstein SA. Alteration of platelet function in dogs mediated by interleukin-6. Blood. 1994 Jan 15; 83(2):398-403. PMID: 7506949.
      Citations: 10     Fields:    Translation:AnimalsCells
    254. Peng J, Friese P, Heilmann E, George JN, Burstein SA, Dale GL. Aged platelets have an impaired response to thrombin as quantitated by P-selectin expression. Blood. 1994 Jan 01; 83(1):161-6. PMID: 7506077.
      Citations: 13     Fields:    Translation:AnimalsCells
    255. Heilmann E, Friese P, Anderson S, George JN, Hanson SR, Burstein SA, Dale GL. Biotinylated platelets: a new approach to the measurement of platelet life span. Br J Haematol. 1993 Dec; 85(4):729-35. PMID: 7918037.
      Citations: 6     Fields:    Translation:AnimalsCells
    256. George JN. Changes in platelet membrane glycoproteins during blood bank storage. Blood Cells. 1992; 18(3):501-11; discussion 512-5. PMID: 1283704.
      Citations: 2     Fields:    Translation:HumansCells
    257. George JN, Shattil SJ. The clinical importance of acquired abnormalities of platelet function. N Engl J Med. 1991 Jan 03; 324(1):27-39. PMID: 1984161.
      Citations: 22     Fields:    Translation:HumansCells
    258. George JN. Platelet immunoglobulin G: its significance for the evaluation of thrombocytopenia and for understanding the origin of alpha-granule proteins. Blood. 1990 Sep 01; 76(5):859-70. PMID: 2203482.
      Citations: 22     Fields:    Translation:HumansCells
    George's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (602)
    Explore
    _
    Co-Authors (30)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _